Scientists Identify Molecule That Kills Kidney Cancer Cells

Scientists at Stanford University School of Medicine claim that they have found a molecule that kills kidney cancer cells.

A molecule that kills kidney cancer cells has been claimed to have been identified by scientists at Stanford University School of Medicine.

The researchers believe that any medicine made from the molecule called STF-62247 may help fight the life-threatening disease without causing any damage to the patient’s kidney.

Moderate Drinking may Lower Risk of Kidney Cancer
Moderate drinking may lower the risk of a type of kidney malignancy called renal cancer according to a study.

"You now have a potential means of going after a disease that’s been difficult to treat," said Dr. Amato Giaccia, professor and director of radiation oncology and radiation biology at the medical school.

Describing the study in the journal Cancer Cell, Giaccia said that his lab focused on kidney cancer because there is no known cure for it short of removing a damaged kidney from a patient’s body.

"There is no effective chemotherapy to treat renal cell carcinoma. Patients still succumb," said Giaccia, also a researcher at the Stanford Cancer Center.

New Kidney Cancer Vaccine Fails at the Last Level
A new kidney cancer vaccine failed in last-phase clinical trials to improve the odds of avoiding remission after tumour-removing surgery, according to a study released Friday.

He said that his study might pave the way for a treatment to save patients from losing one of their two kidneys.

While STF-62247 is toxic to kidney cancer, Giaccia says, it is generally harmless to most other cells in the human body.

Cancer Cells �Reprogram� Energy Needs To Grow And Spread
Researchers have found that cancer cells can reprogram themselves to turn down their own energy-making machinery and use less oxygen, and that these changes might help cancer cells survive and spread.

According to him, patients treated with STF-62247 should not suffer some of chemotherapy’s infamous side effects, like nausea and hair loss, because the molecule is not toxic to the entire body.

Giaccia also said that clinical trials could begin "in the next couple years".

Biomarkers to Gauge Cancer Treatment Effectiveness Identified
Scientists based in The Netherlands have unveiled two potential biomarkers that may enable doctors to monitor the effectiveness of treatment with sunitinib or bevacizumab for kidney,

Source-ANI
RAS/L